Pharmaceutical Companies

October 21, 2020

Purdue Pharma Plea Offers Little Solace to Survivors of Opioid Crisis

The company, which produced OxyContin, faces penalties of $8.3 billion. But families of those addicted are skeptical of the tangible benefits.
September 29, 2020

Appeals court nixes 'negotiation class' created for opioid settlement

The move is a setback for thousands of cities and counties working to streamline a global settlement.
September 9, 2020

N.D. Ohio Preempts Some Opioid Claims (No, Not THAT Case)

The Covid-19 lockdown period is approaching the six-month mark, from mid-March to mid-September. Throughout the spring and summer we have been reading old novels with convoluted plots and surprise endings. Today we take a look at an old case, though only from a prior decade, not a prior century.
August 27, 2020

Pharmacies again ask judge to drop Trumbull opioid suit

The suits, that also target Giant Eagle, CVS, and Rite Aid, allege that between 2000 and 2014, the pharmacies dispensed 68-million doses of opioids in Trumbull County.
August 8, 2020

Federal judge overseeing opioid litigation rejects request to dismiss lawsuits

US District Court of the Northern District of Ohio Judge Dan Polster Friday denied a request by five retail pharmacy chains to dismiss opioid lawsuits filed by two Ohio counties.
August 19, 2020

With Billions at Stake, States Plan Dividing Purdue Opioid Money

Billions from the Purdue Pharma bankruptcy could fund wider use of opioid overdose treatments, programs for babies born addicted, and support programs for mothers and people in jail, according to a draft proposal obtained by Bloomberg Law.
August 14, 2020

Ohio’s lawsuit against drug distributors over opioid crisis set to go before a judge and jury this October

CLEVELAND, Ohio – Ohio is expected to take major drug distributors to trial in October, seeking to hold them responsible for the devastation of the opioid crisis throughout the state.
August 10, 2020

Opioid Scandal Haunts Drug Companies As They Respond To Pandemic

As drug firms race to position themselves as key players in the coronavirus fight, the industry faces a renewed wave of civil lawsuits stemming from its role in the nation's deadly opioid epidemic.